BioAdvice is a GLP and GMP compliant preclinical Contract Research Organisation (CRO) located near Copenhagen, Denmark. The company was established in 1999 and is now driven by a young energetic team of skilled Study Directors, Veterinarians, Animal Technicians and Laboratory Technician.


We offer services within multiple areas of preclinical in-vivo drug testing, with emphasis on metabolism, inflammation and dermatology. We have specialized within pharmacokinetic (PK) and pharmacodynamic (PD) studies in multiple species; mice, rats, rabbits, minipigs, SPF pigs and beagle dogs. Dosing is performed at clinically relevant intervals by various administration routes as; intravenously, intramuscularly, subcutaneously and intradermally. Blood samples will be taken for analysis of test substances aiming at elucidating absorption, distribution, metabolism and excretion of the substances. Blood samples may also be taken for clinical chemistry and/or haematology.


We have a broad portfolio of performed studies, where our experiences and observations, help us continuously improve study designs and refine our technical procedures. E.g.


  • MRI (Magnetic Resonance Imaging) - bone and cartilage healing / repair
  • X-ray (C-arm) and ultrasound
  • Wound healing studies in pigs
  • Inflammatory tests
  • Toxicology studies, single and repeated dosing, local toxicity tests
  • Batch-release tests according to GMP incl. antigenic impurities in guinea pigs
  • Medical device testing
  • Surgical training


The modern facility and highly qualified monitoring skills at BioAdvice ensures high ethical standards with thorough individualised attention to any animal in your studies.

We aim at giving our customers high ethical standards, flexibility and high quality at any time.

BIOADVICE A/S, 21 LYSHØJVEJ, ØLSTYKKE, 3650, DENMARK   +4538252015   BIOADVICE@BIOADVICE.DK

BIOADVICE A/S, 21 LYSHØJVEJ, ØLSTYKKE, 3650, DENMARK   +4538252015

BIOADVICE@BIOADVICE.DK

Go to article: Home | Exoskeletons: one step at a timeGo to article: In this issueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: Braxton Manufacturing Go to article: NewsGo to article: Micro Systems TechnologiesGo to article: Telemed Company InsightGo to article: TelemedGo to article: The Medical Industry BriefingGo to article: Advantech Europe B.V.Go to article: Cap BiomaterialsGo to article: Mobile tech could transform mosquito-borne disease monitoringGo to article: Tricor SystemsGo to article: How professional teeth whitening went mainstreamGo to article: BioadviceGo to article: Predicting the risk of chronic kidney disease with real-world dataGo to article: AccumoldGo to article: Urine testing of people living with HIV may save livesGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Cervical cancer: epigenetic test could improve early detectionGo to article: ARPA Company InsightGo to article: ARPAGo to article: Body composition monitoring: beyond BMI Go to article: Eurofins Company Insight Go to article: EurofinsGo to article: Medical technologies to fight air pollution in our cities Go to article: Advantech Company Insight Go to article: Exoskeleton evolution: A step in the right direction for patients Go to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Scanning cerebral damage in malnourished children Go to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Making robotic surgery safe: why training is key to avoiding tragedy Go to article: Lancor Scientific: transforming cancer screening with blockchainGo to article: GinolisGo to article: Connected medical devices: what challenges as digital healthcare is normalised?Go to article: EventsGo to article: Next Issue